Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Tuesday 6th June, researchers vaccinated volunteers and began Mahidol University’s study of the malaria vaccine RTS,S/AS01.

Mahidol team

This is the first study in Asia of the vaccine, an advanced product that has received regulatory approval in Europe.

Read the full article

Similar stories

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Scientists at the Centre for Medicines Discovery, part of Oxford University’s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.